{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:53:34Z","timestamp":1792464814956,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ejps.2020.105509","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T02:33:22Z","timestamp":1596854002000},"page":"105509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers"],"prefix":"10.1016","volume":"154","author":[{"given":"Sarinj","family":"Fattah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ismaiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Rulikowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus M.","family":"Frias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond C.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Brayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2020.105509_bib0001","first-page":"322","article-title":"A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption","volume":"57","author":"Augustijns","year":"2014","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105509_bib0002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2018.10.009","article-title":"Local delivery of macromolecules to treat diseases associated with the colon","volume":"136\u2013137","author":"Bak","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2020.105509_bib0003","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11102-016-0778-2","article-title":"Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas","volume":"20","author":"Ben-Shlomo","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.ejps.2020.105509_bib0004","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejpb.2019.04.017","article-title":"Biorelevant dissolution testing of a weak base: interlaboratory reproducibility and investigation of parameters controlling in vitro precipitation","volume":"140","author":"Berben","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2020.105509_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5599\/admet.4.1.258","article-title":"Simulated rat intestinal fluid improves oral exposure prediction for poorly soluble compounds over a wide dose range","volume":"4","author":"Berghausen","year":"2016","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.ejps.2020.105509_bib0006","doi-asserted-by":"crossref","unstructured":"Brayden, D.J., Hill, T., Fairlie, D., Maher, S., Mrsny, R., 2020. Systemic delivery of peptides by the oral route: a combination of formulation and medicinal chemistry. [published online ahead of print, 2020 May 29]. Adv Drug Deliv Rev. S0169-409X(20)30040-5. doi:10.1016\/j.addr.2020.05.007.","DOI":"10.1016\/j.addr.2020.05.007"},{"key":"10.1016\/j.ejps.2020.105509_bib0007","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41578-019-0156-6","article-title":"Materials for oral delivery of proteins and peptides","volume":"5","author":"Brown","year":"2020","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ejps.2020.105509_bib0008","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/dia.2019.0185","article-title":"Oral semaglutide: a review of the first oral glucagon-like peptide 1 receptor agonist","volume":"22","author":"Bucheit","year":"2019","journal-title":"Diabet. Technol. Ther."},{"key":"10.1016\/j.ejps.2020.105509_bib0009","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar7047","article-title":"Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist","volume":"10","author":"Buckley","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejps.2020.105509_bib0010","doi-asserted-by":"crossref","first-page":"T141","DOI":"10.1530\/JOE-15-0109","article-title":"60 Years of neuroendocrinology: acromegaly","volume":"226","author":"Capatina","year":"2015","journal-title":"J. Endocrinol."},{"issue":"e2","key":"10.1016\/j.ejps.2020.105509_bib0011","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.clinthera.2011.03.003","article-title":"Comparing the efficacy and tolerability of a new daily oral vitamin B12 formulation and intermittent intramuscular vitamin B12 in normalizing low cobalamin levels: a randomized, open-label, parallel-group study","volume":"33","author":"Castelli","year":"2011","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejps.2020.105509_bib0012","unstructured":"Cumming, K.I., Martin, M.L., 2000. Solid oral dosage form containing heparin or a heparinoid in combination with a carrier. WO2000048589A1."},{"key":"10.1016\/j.ejps.2020.105509_bib0013","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1476-5381.1982.tb09178.x","article-title":"Kinins stimulate net chloride secretion by the rat colon","volume":"75","author":"Cuthbert","year":"1982","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105509_bib0014","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41573-019-0053-0","article-title":"Advances in oral peptide therapeutics","volume":"19","author":"Drucker","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2020.105509_bib0015","first-page":"44","article-title":"Mimicking regional and fasted\/fed state conditions in the intestine with the mucus-PVPA in vitro model: the impact of pH and simulated intestinal fluids on drug permeability","volume":"132","author":"Falavigna","year":"2019","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105509_bib0016","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4155\/tde-2017-0064","article-title":"Progress in the formulation and delivery of somatostatin analogs for acromegaly","volume":"8","author":"Fattah","year":"2017","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejps.2020.105509_bib0017","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/03639045.2016.1251449","article-title":"Optimization of the Ussing chamber setup with excised rat intestinal segments for dissolution\/permeation experiments of poorly soluble drugs","volume":"43","author":"Forner","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2020.105509_bib0018","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0016-5085(91)90651-Z","article-title":"Intestinal absorption of the octapeptide SMS 201-995 visualized by fluorescence derivatization","volume":"100","author":"Fricker","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejps.2020.105509_bib0019","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0022-3565(25)10638-1","article-title":"Enteral absorption of octreotide: modulation of intestinal permeability by distinct carbohydrates","volume":"274","author":"Fricker","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2020.105509_bib0020","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1111\/j.1476-5381.1996.tb15612.x","article-title":"Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation","volume":"118","author":"Fricker","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105509_bib0021","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1476-5381.1992.tb09057.x","article-title":"Enteral absorption of octreotide","volume":"105","author":"Fricker","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105509_bib0022","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1021\/mp500776a","article-title":"Interaction with mixed micelles in the intestine attenuates the permeation enhancing potential of alkyl-maltosides","volume":"12","author":"Gradauer","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2020.105509_bib0023","first-page":"307","article-title":"Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp method","volume":"25","author":"Hess","year":"2005","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105509_bib0024","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1211\/0022357021778583","article-title":"Omeprazole increases permeability across isolated rat gastric mucosa pre-treated with an acid secretagogue","volume":"54","author":"Hopkins","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105509_bib0025","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.jchromb.2011.05.039","article-title":"Determination of octreotide and assessment of matrix effects in human plasma using ultra high performance liquid chromatography\u2013tandem mass spectrometry","volume":"879","author":"Ismaiel","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ejps.2020.105509_bib0026","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2020.105509_bib0027","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1208\/s12248-016-9889-y","article-title":"Gut wall metabolism. application of pre-clinical models for the prediction of human drug absorption and first-pass elimination","volume":"18","author":"Jones","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2020.105509_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/cpph.22","article-title":"The ussing chamber assay to study drug metabolism and transport in the human intestine","volume":"77","author":"Kisser","year":"2017","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105509_bib0029","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejps.2017.02.003","article-title":"Dissolution and dissolution\/permeation experiments for predicting systemic exposure following oral administration of the BCS class II drug clarithromycin","volume":"101","author":"Kristin","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105509_bib0030","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2020.105509_bib0031","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/00498250701704819","article-title":"Intestinal permeability and its relevance for absorption and elimination","volume":"37","author":"Lennern\u00e4s","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejps.2020.105509_bib0032","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1023\/A:1016034913181","article-title":"Oral delivery of sodium cromolyn: preliminary studies in vivo and in vitro","volume":"13","author":"Leone-Bay","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2020.105509_bib0033","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0168-3659(97)00101-6","article-title":"Acylated non-alpha-amino acids as novel agents for the oral delivery of heparin sodium, USP","volume":"50","author":"Leone-Bay","year":"1998","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.ejps.2020.105509_bib0034","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11102-016-0737-y","article-title":"The role of combination medical therapy in the treatment of acromegaly","volume":"20","author":"Lim","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.ejps.2020.105509_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11010041","article-title":"Application of permeation enhancers in oral delivery of macromolecules: an update","volume":"11","author":"Maher","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2020.105509_bib0036","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2018.01.008","article-title":"Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae","volume":"539","author":"Maher","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105509_bib0037","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejps.2009.09.001","article-title":"Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae","volume":"38","author":"Maher","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105509_bib0038","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.addr.2016.06.005","article-title":"Intestinal permeation enhancers for oral peptide delivery","volume":"106","author":"Maher","year":"2016","journal-title":"Adv. Drug Deliv. Rev., Oral Deliv. Pept."},{"key":"10.1016\/j.ejps.2020.105509_bib0039","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.addr.2011.10.006","article-title":"Oral colon delivery of insulin with the aid of functional adjuvants","volume":"64","author":"Maroni","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2020.105509_bib0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2019.08.008","article-title":"Labrasol\u24c7 is an efficacious intestinal permeation enhancer across rat intestine: ex vivo and in vivo rat studies","volume":"310","author":"McCartney","year":"2019","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.ejps.2020.105509_bib0041","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1210\/jc.2014-4113","article-title":"Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial","volume":"100","author":"Melmed","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejps.2020.105509_bib0042","unstructured":"MYCAPSSA [WWW Document], 2020. URLhttps:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/208232s000lbl.pdf."},{"key":"10.1016\/j.ejps.2020.105509_bib0043","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cbpa.2017.04.012","article-title":"Cyclic peptide natural products chart the frontier of oral bioavailability in the pursuit of undruggable targets","volume":"38","author":"Naylor","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejps.2020.105509_bib0044","unstructured":"Novel Approaches for Enhancing the Oral Bioavailability & Absorption of Peptides [WWW Document], 2020. URLhttps:\/\/curtiscoulter.com\/enhancing-oral-bioavailability-absorption-of-peptides\/ (accessed 5.15.20)."},{"key":"10.1016\/j.ejps.2020.105509_bib0045","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.reactfunctpolym.2010.10.002","article-title":"Oral protein delivery: current status and future prospect","volume":"71","author":"Park","year":"2011","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.ejps.2020.105509_bib0046","first-page":"701","article-title":"Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers","volume":"47","author":"Petersen","year":"2012","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105509_bib0047","first-page":"1","article-title":"The history of somatostatin analogs","volume":"28","author":"Pless","year":"2005","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.ejps.2020.105509_bib0048","unstructured":"RYBELSUS\u00ae, 2020. URL: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/213051s000lbl.pdf."},{"key":"10.1016\/j.ejps.2020.105509_bib0050","first-page":"42","article-title":"Cyanocobalamin\/salcaprozate sodium: a novel way to treat vitamin B12 deficiency and anemia","volume":"6","author":"Smith","year":"2016","journal-title":"J. Hematol. Oncol. Pharm."},{"key":"10.1016\/j.ejps.2020.105509_bib0051","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/EJE-15-1042","article-title":"Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly","volume":"174","author":"Strasburger","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ejps.2020.105509_bib0052","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1208\/s12248-020-0416-9","article-title":"Investigations of piperazine derivatives as intestinal permeation enhancers in isolated rat intestinal tissue mucosae","volume":"22","author":"Stuettgen","year":"2020","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2020.105509_bib0053","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1007\/s11095-014-1303-9","article-title":"A novel suspension formulation enhances intestinal absorption of macromolecules via transient and reversible transport mechanisms","volume":"31","author":"Tuvia","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2020.105509_bib0054","series-title":"SNAC and C10, For Oral peptides: Biophysical, in Vitro and Ex Vivo Studies","article-title":"Comparison of the intestinal permeation enhancers","author":"Twarog","year":"2020"},{"key":"10.1016\/j.ejps.2020.105509_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11020078","article-title":"Intestinal permeation enhancers for oral delivery of macromolecules: a comparison between salcaprozate sodium (SNAC) and sodium caprate (C10)","volume":"11","author":"Twarog","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2020.105509_bib0056","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/js970218s","article-title":"Membrane transport of drugs in different regions of the intestinal tract of the rat","volume":"87","author":"Ungell","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105509_bib0057","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejpb.2004.03.023","article-title":"Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs","volume":"58","author":"van der Merwe","year":"2004","journal-title":"Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. Verfahrenstechnik EV"},{"key":"10.1016\/j.ejps.2020.105509_bib0058","first-page":"153","article-title":"Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: an UNGAP review","volume":"134","author":"Vertzoni","year":"2019","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105509_bib0059","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s11095-010-0223-6","article-title":"Biorelevant media to simulate fluids in the ascending colon of humans and their usefulness in predicting intracolonic drug solubility","volume":"27","author":"Vertzoni","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2020.105509_bib0060","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1021\/mp500809f","article-title":"Toward oral delivery of biopharmaceuticals: an assessment of the gastrointestinal stability of 17 peptide drugs","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2020.105509_bib0061","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ijpharm.2014.12.021","article-title":"Evaluation of fasted and fed state simulated and human intestinal fluids as solvent system in the Ussing chambers model to explore food effects on intestinal permeability","volume":"478","author":"Wuyts","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105509_bib0062","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.2042-7158.1997.tb06041.x","article-title":"Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes","volume":"49","author":"Yamamoto","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105509_bib0063","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2165\/11204510-000000000-00000","article-title":"Octreotide long-acting release (LAR): a review of its use in the management of acromegaly","volume":"70","author":"Yang","year":"2010","journal-title":"Drugs"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720302967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720302967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:54:13Z","timestamp":1760529253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720302967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":62,"alternative-id":["S0928098720302967"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105509","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105509"}}